News: AstraZeneca India MD Gagandeep Singh Bedi resigns

Leadership

AstraZeneca India MD Gagandeep Singh Bedi resigns

Sanjeev Panchal has been appointed as the next Managing Director of the drug firm for a period of three years.
AstraZeneca India MD Gagandeep Singh Bedi resigns

AstraZeneca Pharma India’s Managing Director Gagandeep Singh Bedi has resigned.

 Sanjeev Panchal, who has been appointed as the next managing director of the drug firm, will assume charge from January 1, 2023. He will serve as the MD for a period of three years.

At present, Panchal is serving as Country President, AstraZeneca Malaysia. He had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK).

Panchal holds PhD in Business Administration from Aligarh Muslim University. Panchal began his career as sales and marketing roles, cardiovascular (CVTA), Cipla Ltd in 1999.

Read full story

Topics: Leadership

Did you find this story helpful?

Author

QUICK POLL

What is your top focus area for reinventing work in the hybrid world of work?

How can we prepare for a challenging 2023?

READ our latest issue for tips and suggestions.